Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
J Clin Exp Neuropsychol. 2009 Oct;31(7):860-7. doi: 10.1080/13803390802595568. Epub 2009 Jan 14.
Exhaustive neuropsychological assessment of mild cognitive impairment (MCI) subjects frequently identifies cognitive deficits other than memory. However, visuoperception has rarely been investigated in MCI. The 15-Objects Test (15-OT), a visual discrimination task based on the Poppelreuter Test, consists of 15 overlapping objects. Poppelreuter-type tests are frequently used to detect visual agnosia. However, more complex tests, such as the 15-OT, are required to detect visuoperceptual signs in those patients who perform correctly on simple tests. The aim of the present study was to investigate visuoperceptual deficits in MCI patients and to assess the usefulness of the 15-OT to discriminate Alzheimer's disease (AD) and MCI patients from controls. The 15-OT, and a neuropsychological battery included in the diagnostic assessment, was administered to 44 healthy controls, 44 MCI patients, and 44 mild AD patients. Performance on the 15-OT was significantly different between groups. MCI scored between AD and controls. When MCI and AD patients had relatively normal performance on simple tests (Poppelreuter), increased significant abnormalities were found by a more difficult visuoperceptual test (15-OT). Regression analyses showed that the 15-OT was a significant predictor of group membership, but the Poppelreuter Test did not significantly contribute to the models. Visuoperceptual processing is impaired early in the clinical course of AD. The 15-OT allows detection of visuoperceptual deficits in the preclinical and mild AD stages, when classical tests are still unable to detect subtle deficits. So, its inclusion in neuropsychological batteries that are nowadays used in the clinical practice would allow increasing their diagnostic potential.
对轻度认知障碍 (MCI) 患者进行全面的神经心理学评估通常会发现除记忆以外的认知缺陷。然而,MCI 患者的视知觉很少被研究。15-Object Test (15-OT) 是一种基于 Poppelreuter 测试的视觉辨别任务,由 15 个重叠的物体组成。Poppelreuter 型测试常用于检测视觉失认症。然而,对于那些在简单测试中表现正确的患者,需要更复杂的测试,如 15-OT,来检测视知觉迹象。本研究旨在探讨 MCI 患者的视知觉缺陷,并评估 15-OT 区分阿尔茨海默病 (AD) 和 MCI 患者与对照组的有用性。15-OT 和诊断评估中包含的神经心理学测试对 44 名健康对照者、44 名 MCI 患者和 44 名轻度 AD 患者进行了测试。15-OT 的表现在各组之间有显著差异。MCI 患者的得分介于 AD 和对照组之间。当 MCI 和 AD 患者在简单测试(Poppelreuter)中表现相对正常时,通过更困难的视知觉测试(15-OT)发现显著异常增加。回归分析表明,15-OT 是组别的显著预测因素,但 Poppelreuter 测试对模型没有显著贡献。视知觉处理在 AD 的临床早期就受到损害。15-OT 允许在临床前和轻度 AD 阶段检测视知觉缺陷,此时经典测试仍无法检测到细微缺陷。因此,将其纳入当今临床实践中使用的神经心理学测试中,将提高其诊断潜力。